Articles with "plus anti" as a keyword



Photo from wikipedia

Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Medicine"

DOI: 10.1002/cam4.5661

Abstract: Lenvatinib plus anti‐programmed death‐1 (anti‐PD‐1) antibody combinations have shown potent anti‐tumor effect in phase I/II trials in advanced or unresectable hepatocellular carcinoma (HCC), but real‐world data are limited. read more here.

Keywords: hepatocellular carcinoma; plus anti; programmed death; anti programmed ... See more keywords
Photo from wikipedia

Thromboembolic risk assessment in patients receiving combination of anti-angiogenic plus anti-PD1 or anti-PD-L1: A descriptive study

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz449.003

Abstract: Abstract Background Patients (pts) living with cancer are exposed to higher risk for thrombotic event (TE). The thrombotic risk (TR) is related to cancer disease and could also be associated with anti-cancer drugs such as… read more here.

Keywords: risk; anti pd1; plus anti; study ... See more keywords
Photo from wikipedia

Efficacy of a retinoid complex plus anti‐inflammatory component cream alone or in combination with prebiotic food supplement in adult acne: A randomized, assessor‐blinded, parallel‐group, multicenter trial on 184 women

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Cosmetic Dermatology"

DOI: 10.1111/jocd.15074

Abstract: Adult female acne (AFA) nowadays is a very common skin condition affecting mainly women aged between 25 and 40. The treatment of AFA could be challenging. read more here.

Keywords: efficacy retinoid; adult; complex plus; plus anti ... See more keywords
Photo by charlesdeluvio from unsplash

Pegilodecakin Plus Anti-PD-1 Is Tolerable and Effective.

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer discovery"

DOI: 10.1158/2159-8290.cd-rw2019-152

Abstract: Pegilodecakin plus anti-PD-1 showed tolerability and efficacy in some advanced solid tumors. read more here.

Keywords: tolerable effective; plus anti; pegilodecakin plus; anti tolerable ... See more keywords
Photo by jblesly from unsplash

Safety and Immunological Evaluation of Interleukin-21 Plus Anti-α4β7 mAb Combination Therapy in Rhesus Macaques

Sign Up to like & get
recommendations!
Published in 2020 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2020.01275

Abstract: Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections compromise gut immunological barriers, inducing high levels of inflammation and a severe depletion of intestinal CD4+ T cells. Expression of α4β7 integrin promotes homing of… read more here.

Keywords: anti mab; plus anti; rhesus macaques; therapy ... See more keywords